在新诊断的乙型肝炎感染中使用Ribociclib:一个病例报告
Fabrizio Di Costanzo1, Simone Carrano1, Gennaro Iengo1
1Division of Medical Oncology, Department of Clinical Medicine, University of Naples Federico II, Naples, Italy.
Frontiers in oncology
|June 26, 2023
概括
这项案例研究表明,一种转移性乳腺癌患者患有乙型肝炎,成功接受了Ribociclib的治疗. 该疗法在没有肝脏毒性的情况下控制了感染和癌症,证明了可行的治疗选择.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌是全球女性的主要癌症.
- CDK4/6抑制剂利博西克利布已批准用于转移性激素阳性,HER2阴性乳腺癌.
- 伴随性疾病,如乙型肝炎感染,可能会限制利博西克利布的治疗资格.
研究的目的:
- 报告患有乙型肝炎的患者转移性乳腺癌病例.
- 评估Ribociclib在这个患者的安全性和有效性.
- 评估利博西克利布对乙型肝炎阳性患者肝功能的影响.
主要方法:
- 一名45岁的女性患有转移性乳腺癌和乙型肝炎感染,接受了治疗.
- 该患者接受了乙型肝炎的根除疗法,随后接受了Ribociclib.
- 在整个瘤治疗过程中,肝功能受到密切监测.
主要成果:
- 患者完成了Ribociclib的瘤治疗,没有发生肝毒性.
- 肝功能测试保持稳定,没有过氨基酶或胆红素的增加.
- 患者获得了部分反应,然后病情稳定,表明有效控制癌症.
结论:
- 利博西克利布可以安全地给转移性乳腺癌患者和乙型肝炎感染.
- 有效管理乙型肝炎和利博西克利布治疗可以导致有利的瘤结果.
- 这一案例凸显了管理并发病症和继续有效的癌症治疗的潜力.
相关概念视频
Diseases of the Liver and Gallbladder
674
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
674
Hepatic Drug Excretion: Enterohepatic Cycling
1.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.6K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177
Subviral Agents
48
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
48


